Sera from Greek and Italian patients with sporadic ALS contain more LRP4 autoantibodies (23.4%) than sera from patients with other neurological diseases (3.6%) or from healthy controls [48]. This evidence concerns the gene LRP4 and amyotrophic lateral sclerosis.